Skip to content
Open access

Isolation and phenotypic characterization of bacteriophages targeting multidrug-resistant biofilm-forming uropathogenic Escherichia coli from hospital sewage

Oct 2026 · Scientific Reports · 0 citations

TL;DR

Preliminary in-vitro phenotypic evidence is provided and support further genomic, structural, and biological characterization of bacteriophages targeting MDR and biofilm-forming UPEC from hospital sewage in Ethiopia.

Abstract

Uropathogenic Escherichia coli (UPEC) is a major cause of urinary tract infections (UTIs), with multidrug resistance (MDR) and biofilm formation complicating treatment. This study isolated and phenotypically characterized bacteriophages targeting MDR and biofilm-forming UPEC from hospital sewage in Ethiopia. Twenty-three archived MDR UPEC isolates were screened for biofilm formation, and phages were characterized by host range, efficiency of plating, multiplicity of infection (MOI), adsorption kinetics, one-step growth, environmental stability, and biofilm biomass reduction. Eight isolates (34.8%) formed biofilms, including 3 strong, 1 moderate, and 4 weak biofilm formers. Two phages, ΦET-3175 and ΦFETA-207, were isolated with titers of 1.35 × 10⁹ and 1.12 × 10⁹ PFU/mL, respectively. ΦET-3175 showed broader activity, with detectable activity against 6/23 (26.1%) isolates, an optimal MOI of 0.1, > 95% adsorption within 20 min, a latent period of approximately 30 min, and a burst size of 147 ± 4.6 PFU per infected cell. Both phages retained detectable activity across pH 4–10 and at temperatures up to 50 °C. ΦET-3175 reduced biofilm biomass by 3.2–39.5% among four susceptible biofilm-forming isolates, but the paired difference was not statistically significant (Z = − 1.826, p  = 0.068). These findings provide preliminary in-vitro phenotypic evidence and support further genomic, structural, and biological characterization.

Read PDF

Similar papers

Open access Sep 2026

Phage–Antibiotic–Peptide Synergy Overcomes Biofilm-Mediated Multidrug Resistance in Serratia marcescens

It is demonstrated that simultaneous targeting of multiple bacterial pathways can enhance antimicrobial activity against MDR S. marcescens in vitro and support further evaluation of BAP as a potential strategy for biofilm-associated infections.

Aryaan P. Duggal, Adit B. Alreja, Isha Vashee et al. · 0 citations
Open access Oct 2026

Draft Genome and Phenotypic Characterization of an Adherent, Biofilm-Forming Uropathogenic Escherichia coli Strain (HU5) Isolated from Urinary Tract Infection in Mexico

Uropathogenic Escherichia coli (UPEC) is the main cause of urinary tract infections (UTIs), and its clinical success depends on adherence and colonization of the urothelium. Most publicly deposited UPEC genomes lack accompanying phenotypic validation of adherence or biofilm capacity, limiting genotype–phenotype linkage...

Pablo A. Méndez-Pfeiffer, Bryan Ortíz, Yessica Enciso-Martínez et al. · 0 citations
Sep 2026

Integrated Phenotypic and Molecular Characterization of Biofilm Formation, Virulence Determinants, and Multidrug Resistance in Clinical Escherichia Coli

Background: Escherichia coli is responsible for the majority of UTI cases, with an increasing number of multidrug resistance (MDR) and biofilm-forming E. coli isolates being isolated from such cases. In this study, we assessed the MDR profile, biofilm formation ability, and occurrence of specific biofilm-associated and...

Hiba Mohssin Ali · 0 citations
Open access Sep 2026

Molecular epidemiology of multidrug-resistant uropathogenic Escherichia coli: Virulence, biofilm formation, phylogenetic distribution, and genetic diversity.

BACKGROUND Multidrug-resistant (MDR) Escherichia coli mediated urinary tract infections (UTIs) are an increasing public health concern, especially in low- and middle-income nations. This study aimed to determine the prevalence, antimicrobial resistance and virulence profile, biofilm forming ability with phylogenetic di...

Md. Tanjir Ahmmed, Bushra Benta Rahman Prapti, T. Islam et al. · 0 citations
Open access Oct 2026

Targeting Multidrug-Resistant Pseudomonas aeruginosa from Companion Animals Using Bacteriophages

Antimicrobial resistance poses a major challenge to veterinary and human medicine, particularly in the context of difficult-to-treat infections caused by multidrug-resistant (MDR) bacteria. Pseudomonas aeruginosa, a WHO priority pathogen, is known for its resistance profile and ability to form biofilms. As an alternati...

Margarida C. Gomes, Patricia Boto, M. Oliveira et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.